Letouz E, Martinelli C, Loriot C, Burnichon N, Abermil N, Ottolenghi C, Janin M, Menara M, Nguyen AT, Benit P, Buffet A, Marcaillou C, Bertherat J, Amar L, Rustin P, De Reynis A, Gimenez-Roqueplo AP, Favier J
A clinically defensible pathway therefore requires standardizing pre-analytics (cycle type, progesterone route, biopsy timing/site), clarifying the clinical question (timing correction vs endotype diagnosis), and integrating receptivity readouts with complementary layers when disruption is suspected, such as immune profiling and endometrial/uterine fluid proteomics/metabolomics, so that non-receptive is interpreted within a multi-dimensional endometrial endotype framework rather than as a single timing label
Keeping track of any changes can help identify if the combination is causing any issues
Millions of people in the US have used semaglutide medicines to help address these chronic conditions, yet there are still patients without adequate coverage seeking improved access
Know the signs of hypoglycemia If you're taking semaglutide, it's worth knowing the early signs of hypoglycemia: lightheadedness, anxiety , palpitations, shakiness, and unusual sweating